Aligos Therapeutics Statistics
NASDAQ: ALGSHealthcareBiotechnologyUSD
5.31-0.01 (-0.19%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Aligos Therapeutics by the numbers
Aligos Therapeutics has a market capitalization of $33.2 million based on 5.44M shares outstanding. With trailing EPS of $-7.33, Aligos Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.5% below its 50-day average and 19.5% below its 200-day average.
Average daily trading volume is 88.98K shares, or about $472,463 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALGS valuation vs. peer median
| Metric | ALGS | Peer median | Difference |
|---|---|---|---|
| Market cap | $33.16M | $34.03M | -3% |
| Avg. volume | 88.98K | 190.22K | -53% |
Peer median across 8 companies: NNVC, ATNM, BCTX, GRDX, CVM, IBO, NXTC, QNCX.
Valuation
- Market cap
- $33.16M
- EPS (TTM)
- $-7.33
- Shares outstanding
- 5.44M
Price and trading
- Previous close
- 5.32
- Open
- 5.25
- Day range
- 5.08 – 5.49
- 52-week range
- 3.98 – 13.69
- 52-week change
- -46.53%
- Beta
- —
- Volume
- 37.36K
- Average volume
- 88.98K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 33.16M
- Forward Pe
- -1.01
- Eps
- -7.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.69
- Week52 Low
- 3.98
- Avg Volume
- 88,976.00
- Shares Outstanding
- 5.44M
- Ma50
- 5.87
- Ma200
- 6.59
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -61.21%
- Pct From52w Low
- 33.42%